PowderMed
6
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B Infection
Role: lead
A Safety Study to Assess a DNA Vaccine Administered by Particle Mediated Delivery to the Skin in Healthy Subjects
Role: lead
Safety Study of an Influenza Vaccine Against a Potential Pandemic Strain of Flu
Role: lead
A Safety and Immunology Study of a DNA Trivalent Influenza Vaccine
Role: lead
Safety Study of HSV2 DNA Vaccine to Treat Patients With Recurrent Genital Herpes Caused by HSV-2
Role: lead
Study of the Ability of a Flu Vaccine to Prevent Flu Infection
Role: lead
All 6 trials loaded